Rus
Eng
5th International Conference «Nanobiophysics: Fundamental and Applied Aspects» was held on October 2-5, 2017 at B. Verkin Institute for Low Temperature Physics and Engineering of the NAS of Ukraine, Kharkiv, Ukraine.
A special session dedicated to HORIZON 2020 project «Asymmetry of biological membrane: theoretical, experimental and applied aspects» (690853 – assymcurv – H2020-MSCA-RISE-2015/H2020-MSCA-RISE-2015) was organized.
Oleksiy Gogotsi, director of Materials Research Center presented research on synthesis and biomedical applications of 2D carbides MXenes.
Two-dimensional (2D) materials with a thickness of a few nanometers or less can be used as single sheets due to their unique properties or as building blocks, to assemble a variety of structures. The family of two-dimensional (2D) transition metal carbides and nitrides, MXenes, has been expanding rapidly since the discovery of Ti3C2 in 2011. More than 20 different MXenes have been synthesized, and the structure and properties of numerous other MXenes have been predicted using density functional theory calculations. MXenes’ versatile chemistry renders their properties tunable for a large variety of applications. Oxygen or OH terminated MXenes, such as Ti3C2O2, are promising candidates for biomedical applications.
Download PDF version of Synthesis and Biomedical Applications Of 2D Carbides (MXenes)
Conference Organizers: B. Verkin Institute for Low Temperature Physics and Engineering of NASU and Institute of Physics of NASU.
Urgent problems in a new scientific field combining biophysics and nanotechnology as well as its progress and prospects were discussed during the following sessions:
– Nanobiohybrids formed by nanocarbon materials with bioobjects
– Biomolecules on nanoparticles and nanostructured surfaces
– Physical aspects of biomolecular nanosystems
– Theoretical calculations and computer modeling of nanobiosystems
– Applied aspects of nanobiophysics
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Our team was very delighted to take part in International Symposium "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene event in Europe this year! 
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.